We have located links that may give you full text access.
Weakly supervised deep learning predicts immunotherapy response in solid tumors based on PD-L1 expression.
Cancer Res Commun 2023 December 22
Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) is the most commonly used biomarker for immunotherapy response. However, quantification of PD-L1 status in pathology slides is challenging. Neither manual quantification nor a computer-based mimicking of manual readouts are perfectly reproducible, and the predictive performance of both approaches regarding immunotherapy response is limited. In this study, we developed a deep learning (DL) method to predict PD-L1 status directly from raw IHC image data, without explicit intermediary steps such as cell detection or pigment quantification. We trained the weakly supervised model on PD-L1-stained slides from the NSCLC-MSK cohort (N=233) and validated it on the pancancer-VHIO cohort (N=108). We also investigated the performance of the model to predict response to immune checkpoint inhibitors (ICIs) in terms of progression-free survival (PFS). In the pancancer-VHIO cohort, the performance was compared with Tumor Proportion Score (TPS) and Combined Positive Score (CPS). The DL-model showed good performance in predicting PD-L1 expression (TPS≥1%) in both NSCLC-MSK and pancancer-VHIO cohort (AUC 0.88±0.06 and 0.80±0.03, respectively). The predicted PD-L1 status showed an improved association with response to ICIs (hazard ratio (HR) 1.5[95%CI 1-2.3], p-value=0.049) compared to TPS (HR 1.4[0.96-2.2], p-value=0.082) and CPS (HR 1.2[0.79-1.9], p-value=0.386). Notably, our explainability analysis showed that the model does not just look at the amount of brown pigment in the IHC slides, but also considers morphological factors such as lymphocyte conglomerates. Overall, end-to-end weakly supervised DL shows potential for improving patient stratification for cancer immunotherapy by analyzing PD-L1 immunohistochemistry, holistically integrating morphology and PD-L1-staining intensity.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.Gut 2024 April 17
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Ventilator Waveforms May Give Clues to Expiratory Muscle Activity.American Journal of Respiratory and Critical Care Medicine 2024 April 25
Systemic lupus erythematosus.Lancet 2024 April 18
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app